<p>銀背生物科技公司（NASDAQ:SBTX - 獲取免費報告）在週一的午盤交易中下跌了 6.9%。該公司的股價最低曾達到 11.89 美元，最後交易價為 11.92 美元。在午盤交易中，約有 1,370,275 股成交，較平均每日成交量 337,931 股增加了 305%。該股票此前收盤價為 12.80 美元。</p>
<h2>銀背生物科技股票下跌 6.9%</h2>
<p>該公司的市值為 4.2981 億美元，市盈率為-4.93，貝塔值為 0.60。該股票的 50 日簡單移動平均線為 12.32 美元，200 日簡單移動平均線為 13.07 美元。</p>
<h2>銀背生物科技公司簡介</h2>
<p>（獲取免費報告）</p>
<p>銀背生物科技公司是一家生物製藥公司，開發針對慢性病毒感染、癌症和其他嚴重疾病的組織靶向治療藥物。該公司提供 SBT8230，用於通過靶向 TLR8 激活到肝臟，誘導抗病毒免疫反應來治療慢性乙型肝炎病毒感染。</p>
<h2>精選故事</h2>
<ul>
<li>五隻我們更看好的股票超過銀背生物科技</li>
<li>TSX 風險投資交易所（前身為加拿大風險投資交易所）</li>
<li>默克：購買此跌幅的四個不容錯過的理由</li>
<li>尋找並盈利交易 52 周低點的股票</li>
<li>阿克曼宣佈在優步的重大股份：你應該跟隨他的腳步嗎？</li>
<li>FAANG 股票是什麼，它們是好的投資嗎？</li>
<li>富國銀行升級了這三隻股票——它們為何脱穎而出</li>
</ul>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。如有任何問題或意見，請發送至 contact@marketbeat.com.</em></p>
<h2>你現在應該投資 1000 美元嗎？</h2>
<p>在你進行下一筆交易之前，你會想聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。</p>
<p>我們的團隊已確定五隻頂級分析師正在悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而且沒有大名鼎鼎的股票在名單上。</p>
<p>他們認為這五隻股票是投資者現在購買的五家最佳公司……</p>
<p>查看這五隻股票</p>
<h2>你現在應該投資 1000 美元在銀背生物科技嗎？</h2>
<p>在你考慮銀背生物科技之前，你會想聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已確定五隻頂級分析師正在悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而銀背生物科技並不在名單上。</p>
<p>雖然銀背生物科技目前在分析師中有 “持有” 評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>查看這五隻股票</p>

SBTX

<p>銀背治療公司（NASDAQ:SBTX）股價在午盤交易中下跌 6.9%，至 11.92 美元，交易量較平均水平增加了 305%。該公司的市值為 4.2981 億美元，市盈率為-4.93。分析師目前對該股票的評級為 “持有”，但建議有更好的投資選擇。銀背治療專注於開發針對慢性病毒感染和癌症的治療藥物</p>

<p>Silverback Therapeutics, Inc. (NASDAQ:SBTX - Get Free Report) was down 6.9% during mid-day trading on Monday . The company traded as low as $11.89 and last traded at $11.92. Approximately 1,370,275 shares traded hands during mid-day trading, an increase of 305% from the average daily volume of 337,931 shares. The stock had previously closed at $12.80.</p>
<div class="lb-trans"><p>銀背生物科技公司（NASDAQ:SBTX - 獲取免費報告）在週一的午盤交易中下跌了 6.9%。該公司的股價最低曾達到 11.89 美元，最後交易價為 11.92 美元。在午盤交易中，約有 1,370,275 股成交，較平均每日成交量 337,931 股增加了 305%。該股票此前收盤價為 12.80 美元。</p>
</div><h2>Silverback Therapeutics Stock Down 6.9 %</h2>
<div class="lb-trans"><h2>銀背生物科技股票下跌 6.9%</h2>
</div><p>The company has a market capitalization of $429.81 million, a price-to-earnings ratio of -4.93 and a beta of 0.60. The stock has a 50 day simple moving average of $12.32 and a 200 day simple moving average of $13.07.</p>
<div class="lb-trans"><p>該公司的市值為 4.2981 億美元，市盈率為-4.93，貝塔值為 0.60。該股票的 50 日簡單移動平均線為 12.32 美元，200 日簡單移動平均線為 13.07 美元。</p>
</div><h2>Silverback Therapeutics Company Profile</h2>
<div class="lb-trans"><h2>銀背生物科技公司簡介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>Silverback Therapeutics, Inc, a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver.</p>
<div class="lb-trans"><p>銀背生物科技公司是一家生物製藥公司，開發針對慢性病毒感染、癌症和其他嚴重疾病的組織靶向治療藥物。該公司提供 SBT8230，用於通過靶向 TLR8 激活到肝臟，誘導抗病毒免疫反應來治療慢性乙型肝炎病毒感染。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精選故事</h2>
</div><ul>
<li>Five stocks we like better than Silverback Therapeutics</li>
<li>TSX Venture Exchange (Formerly Canadian Venture Exchange)</li>
<li>Merck: 4 No-Brainer Reasons to Buy This Dip</li>
<li>Find and Profitably Trade Stocks at 52-Week Lows</li>
<li>Ackman Announces Major Stake in Uber: Should You Follow His Lead?</li>
<li>What Are the FAANG Stocks and Are They Good Investments?</li>
<li>Wells Fargo Upgraded These 3 Stocks—Here’s Why They Stand Out</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票超過銀背生物科技</li>
<li>TSX 風險投資交易所（前身為加拿大風險投資交易所）</li>
<li>默克：購買此跌幅的四個不容錯過的理由</li>
<li>尋找並盈利交易 52 周低點的股票</li>
<li>阿克曼宣佈在優步的重大股份：你應該跟隨他的腳步嗎？</li>
<li>FAANG 股票是什麼，它們是好的投資嗎？</li>
<li>富國銀行升級了這三隻股票——它們為何脱穎而出</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。如有任何問題或意見，請發送至 contact@marketbeat.com.</em></p>
</div><h2>Where Should You Invest $1,000 Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1000 美元嗎？</h2>
</div><p>Before you make your next trade, you'll want to hear this.</p>
<div class="lb-trans"><p>在你進行下一筆交易之前，你會想聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。</p>
</div><p>Our team has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and none of the big name stocks were on the list.</p>
<div class="lb-trans"><p>我們的團隊已確定五隻頂級分析師正在悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而且沒有大名鼎鼎的股票在名單上。</p>
</div><p>They believe these five stocks are the five best companies for investors to buy now...</p>
<div class="lb-trans"><p>他們認為這五隻股票是投資者現在購買的五家最佳公司……</p>
</div><p>See The Five Stocks Here</p>
<div class="lb-trans"><p>查看這五隻股票</p>
</div><h2>Should You Invest $1,000 in Silverback Therapeutics Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1000 美元在銀背生物科技嗎？</h2>
</div><p>Before you consider Silverback Therapeutics, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考慮銀背生物科技之前，你會想聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Silverback Therapeutics wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已確定五隻頂級分析師正在悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而銀背生物科技並不在名單上。</p>
</div><p>While Silverback Therapeutics currently has a &#34;Hold&#34; rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然銀背生物科技目前在分析師中有 “持有” 評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看這五隻股票</p>
</div>

Silverback Therapeutics（納斯達克股票代碼：SBTX）股價下跌 6.9% - 以下是原因